BioSpace News Archive

Daxor Corporation(NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that the U.S. Air Force (USAF) has awarded Daxor a contract to define specifications to adapt blood volume analysis technology to meet the needs of USAF.

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Thomas C. Wessel, M.D., Ph.D., has been appointed the Company’s Executive Vice President and Head of Research and Development.

Report Highlights Excellence in Promoting Sustainable Operations, Inspiring Associates and Supporting Healthy Communities

In an effort to prevent the spread of illness and ease anxiety about novel coronavirus COVID-19, Spectrum Health is offering free virtual screenings for people who are concerned they may have the virus.

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), today announced the hiring of Robert McKague as Executive Vice President, General Counsel and Chief Compliance Officer.

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that it has made the decision to begin production of NP-120 (Ifenprodil) with a new injectable and long acting oral release formulation, in order to be prepared for new US clinical trials for COVID-19 (coronavirus) and acute lung injury (ALI).

Trinity Life Sciences, a leader in global life sciences solutions, announces the availability of the first and only end-to-end market access consulting solution for biopharmaceutical companies.

Advanced technology to aid in recovery of stroke, spinal cord injury and brain injury

Expands national footprint to 250 employer-sponsored health centers and augments clinical expertise with licensure of SentryHealth’s population health management software

The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products.